PRLAX | RLAIX | PRLAX / RLAIX | |
Total Expense Ratio | 1.46 | 1.08 | 135% |
Annual Report Gross Expense Ratio | 1.46 | 1.19 | 123% |
Fund Existence | 32 years | 9 years | - |
Gain YTD | 32.286 | 32.672 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 391M | 391M | 100% |
Annual Yield % from dividends | 2.60 | 3.07 | 85% |
Returns for 1 year | 10.13 | 10.53 | 96% |
Returns for 3 years | 24.58 | 25.95 | 95% |
Returns for 5 years | 36.48 | 38.71 | 94% |
Returns for 10 years | 50.24 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CECYX | 30.17 | 0.18 | +0.60% |
Columbia Large Cap Enhanced Core Inst3 | |||
GMVIX | 16.67 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
RLBAX | 38.62 | 0.04 | +0.10% |
American Funds American Balanced R1 | |||
FCVCX | 15.38 | N/A | N/A |
Fidelity Advisor Small Cap Value C | |||
TLISX | 13.85 | -0.09 | -0.65% |
Nuveen Quant Intl Small Cap Eq A |